Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-Il2 Receptor Monoclonal Antibodies?

American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.13884
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley